Castle Biosciences, Inc. (CSTL)

USD 19.89

(0.96%)

Inventory Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual inventory in 2023 was 7.94 Million USD , up 99.55% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly inventory in 2024 Q1 was 7.64 Million USD , down -3.74% from previous quarter.
  • Castle Biosciences, Inc. reported annual inventory of 3.98 Million USD in 2022, up 96.93% from previous year.
  • Castle Biosciences, Inc. reported annual inventory of 2.02 Million USD in 2021, down -8.84% from previous year.
  • Castle Biosciences, Inc. reported quarterly inventory of 7.64 Million USD for 2024 Q1, down -3.74% from previous quarter.
  • Castle Biosciences, Inc. reported quarterly inventory of 8.01 Million USD for 2024 Q2, up 4.81% from previous quarter.

Annual Inventory Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Inventory of Castle Biosciences, Inc. (2023 - 2017)

Year Inventory Inventory Growth
2023 7.94 Million USD 99.55%
2022 3.98 Million USD 96.93%
2021 2.02 Million USD -8.84%
2020 2.21 Million USD 79.22%
2019 1.23 Million USD 40.21%
2018 882.23 Thousand USD 189.66%
2017 304.57 Thousand USD 0.0%

Peer Inventory Comparison of Castle Biosciences, Inc.

Name Inventory Inventory Difference
Aspira Women's Health Inc. 227 Thousand USD -3398.678%
bioAffinity Technologies, Inc. 18.48 Thousand USD -42866.89%
Intelligent Bio Solutions Inc. 777.53 Thousand USD -921.43%
Standard BioTools Inc. 20.53 Million USD 61.321%
Inotiv, Inc. 56.1 Million USD 85.844%
Prenetics Global Limited 3.12 Million USD -154.0%
Neuronetics, Inc. 8.09 Million USD 1.866%
Star Equity Holdings, Inc. 3.42 Million USD -132.222%
Psychemedics Corporation 1.00 USD -794199900.0%
RadNet, Inc. 1.00 USD -794199900.0%
Exact Sciences Corporation 127.47 Million USD 93.77%
IDEXX Laboratories, Inc. 380.28 Million USD 97.912%
iSpecimen Inc. - USD -Infinity%
OpGen, Inc. 1.00 USD -794199900.0%
Exagen Inc. 2.87 Million USD -176.628%
Bionano Genomics, Inc. 22.89 Million USD 65.308%
CareDx, Inc 19.47 Million USD 59.211%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 32.06 Million USD 75.23%
Guardant Health, Inc. 61.94 Million USD 87.18%
Biodesix, Inc. 1.4 Million USD -467.286%
BioNexus Gene Lab Corp. 1.13 Million USD -598.032%
Precipio, Inc. 384 Thousand USD -1968.229%
Natera, Inc. 40.75 Million USD 80.515%
Fulgent Genetics, Inc. 5.82 Million USD -36.297%
Sera Prognostics, Inc. - USD -Infinity%
23andMe Holding Co. 12.46 Million USD 36.286%
OPKO Health, Inc. 65.69 Million USD 87.911%
Personalis, Inc. 5.66 Million USD -40.293%
Aclaris Therapeutics, Inc. - USD -Infinity%
Applied DNA Sciences, Inc. 330.02 Thousand USD -2306.47%
T2 Biosystems, Inc. 4.81 Million USD -64.806%
Neogen Corporation 189.26 Million USD 95.804%
Myriad Genetics, Inc. 20.1 Million USD 60.488%
ICON Public Limited Company 1.00 USD -794199900.0%
NeoGenomics, Inc. 24.15 Million USD 67.122%
Star Equity Holdings, Inc. 3.42 Million USD -132.222%
MDxHealth SA 2.77 Million USD -185.786%
Prenetics Global Limited 3.12 Million USD -154.0%
Illumina, Inc. 587 Million USD 98.647%
DarioHealth Corp. 5.06 Million USD -56.895%
ENDRA Life Sciences Inc. 2.62 Million USD -202.799%
Medpace Holdings, Inc. 1.00 USD -794199900.0%
Mainz Biomed B.V. 613.63 Thousand USD -1194.248%
Trinity Biotech plc 19.93 Million USD 60.157%
Sotera Health Company 51.98 Million USD 84.723%
bioAffinity Technologies, Inc. 18.48 Thousand USD -42866.89%